• Profile
Close

Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit

Cancer Jun 23, 2018

Pastores SM, et al. - In this retrospective, single-center study, researchers assessed the outcomes, both short- and long-term, of patients with hematologic malignancies who had chemotherapy in the intensive care unit (ICU) vs a matched cohort of ICU patients who did not receive chemotherapy. Using conditional logistic regression and shared-frailty Cox regression, they evaluated short-term (ICU and hospital) mortality and death within 12 months of hospital discharge, respectively. Data showed ICU and hospital mortality rates in chemotherapy patients were 25% and 42% vs 22% and 33% for non-chemotherapy patients. In both the patient groups, similar short-term mortality was found. Increased resource utilization by patients who received chemotherapy was also observed.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay